Your browser doesn't support javascript.
loading
Dual target dilemma: navigating epcoritamab vs. glofitamab in relapsed refractory diffuse large B-cell lymphoma.
Davis, James A; Granger, Katelynn; Sakowski, Alex; Goodwin, Sara; Herbst, Amanda; Smith, Deidra; Hendrickson, Lindsey; Nachar, Victoria R.
Afiliação
  • Davis JA; Department of Malignant Hematology and Bone Marrow Transplant, The Medical University of South Carolina Hollings Cancer Center, Charleston, SC, USA.
  • Granger K; Department of Malignant Hematology and Bone Marrow Transplant, The Medical University of South Carolina Hollings Cancer Center, Charleston, SC, USA.
  • Sakowski A; Department of Malignant Hematology and Bone Marrow Transplant, The Medical University of South Carolina Hollings Cancer Center, Charleston, SC, USA.
  • Goodwin S; Department of Malignant Hematology and Bone Marrow Transplant, The Medical University of South Carolina Hollings Cancer Center, Charleston, SC, USA.
  • Herbst A; Department of Malignant Hematology and Bone Marrow Transplant, The Medical University of South Carolina Hollings Cancer Center, Charleston, SC, USA.
  • Smith D; Department of Malignant Hematology and Bone Marrow Transplant, The Medical University of South Carolina Hollings Cancer Center, Charleston, SC, USA.
  • Hendrickson L; Department of Malignant Hematology and Bone Marrow Transplant, The Medical University of South Carolina Hollings Cancer Center, Charleston, SC, USA.
  • Nachar VR; Department of Pharmacy, University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA.
Expert Rev Hematol ; 16(12): 915-918, 2023.
Article em En | MEDLINE | ID: mdl-37982732
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin / Linfoma Difuso de Grandes Células B / Anticorpos Biespecíficos / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin / Linfoma Difuso de Grandes Células B / Anticorpos Biespecíficos / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article